Dextran-Polyacrylamide as Matrices for Creation of Anticancer Nanocomposite

Figure 5

The percentage of viable U-937 (a) and K-562 (b) cells after incubation with the nanoparticles D-g-PAA(PE) and D-g-PAA(PE)/cisplatin assessed by Trypan Blue staining. The nanoparticles were added at concentration of 5 μg/mL D-g-PAA(PE)/cisplatin. Data are means ± SD; difference between two groups ().

(a)

(b)